Epidural magnesium reduces postoperative analgesic requirement

Area of Science:

• Anesthesiology
• Pharmacology
• Pain Management

Background:

• Magnesium demonstrates antinociceptive properties in various pain models.
• The study investigated magnesium's potential to reduce fentanyl requirements in postoperative pain management.

Purpose of the Study:

• To evaluate the efficacy of adding magnesium sulphate to epidural fentanyl analgesia for hip surgery patients.
• To determine if magnesium reduces overall fentanyl consumption and impacts pain scores post-operatively.

Main Methods:

• A randomized controlled trial involving 50 hip surgery patients receiving 24-hour epidural analgesia.
• Patients received either fentanyl alone (Group F) or fentanyl plus magnesium sulphate (Group FM) via patient-controlled epidural analgesia.
• Key metrics included fentanyl consumption, visual analogue scale (VAS) pain scores, and hemodynamic/respiratory variables.

Main Results:

• Group FM showed significantly lower cumulative 24-hour epidural fentanyl consumption compared to Group F (328 vs. 437 microg).
• Patients in Group F reported higher VAS pain scores in the first postoperative hour.
• No significant differences were observed in time to first analgesic requirement, hemodynamic stability, respiratory function, sedation, or incidence of pruritus and nausea.

Conclusions:

• Co-administration of magnesium with epidural fentanyl effectively reduces postoperative opioid requirements.
• Magnesium supplementation in epidural analgesia appears safe and well-tolerated, without increasing side effects.